Inhtravitreal triamcinolone acetonide injections in the treatment of cystoid macular edema due to the central or branch retinal vein occlusion;Zastosowanie iniekcji octanu triamcinolonu w leczeniu torbielowatego obrzeku plamki w przebiegu zakrzepu żyły środkowej siatkówki

Klinika Oczna

Volumn 109, Issue 4-6, 2007, Pages 169-172

  Lubczyńska, Anna ^a,b   Kocicecki, Jarosław ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b NONE   (Poland)

Author keywords

Branch retinal vein occlusion; Central retinal vein occlusion; Cystoid macula edema; Triamcinolone acetonide

Indexed keywords

EID: 34447521447     PISSN: 00232157     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bashshur ZF, Ma'luf RN, Allam S, Jurdi FA, Haddad RS, Noureddin BN: Intravitreal triamcinolone for management of macular edema due to nonischemic central vein occlusion. Arch Ophthalmol 2004, 122, 1137-1140.
2. Bhagat N, Goldberger MF, Gascon P, Bell W, Haberman J, Zarbin MA: Central retinal vein occlusion:review of management. Eu J Ophthalmol 1999, 9(3), 165-180.
3. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997, 115, 486-491.
4. The Branch Vein Occlusion Study Group. Argon Laser photo-coagulation for macular edema in branch vein occlusion. A J Ophthalmol 1984, 98, 271-282.
5. Jonas JB, Kressig I, Degenring R: Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases. Progress in retinal and eye Research 2005, 24, 587-611.
6. Jonas JB, Kressig I, Kamppeter B, Degenring RF: Intravitreales Triamcinolone-acetonid zur Behandlung intraokulärer ödematöser und neovaskulärer Erkrankungen. Ophthalmologe 2004, 101, 113-120.
7. Ip MS, Gottlieb JL, Kahana A, Scott IU, Altaweel MM, Blodi BA, Gangnon RE, Puliafito CA: Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 2004, 122, 1131-1136.
8. Krepier K, Ergun E, Sacu S, Richter-Müksch S, Wagner J, Stur M, Wedrich A: Intravitreal triamcinolne acetonid in patients with macular oedema due to central retinal vein occlusion. Acta Ophthalomol Scand 2005, 83, 71-75.
9. Jonas JB, Akkoyun I, Kamppeter B, Kressig I, Degenring RF: Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye 2005, 19, 65-71.
10. Lerche RC, Schaudig U, Scholz F, Walter A, Richard G: Structural changes of the retina in retinal vein occlusion - imaging and quantification with optical coherence tomography. Ophthalmic Surg Lasers 2001, 32, 272-280.
11. Polito A, Shah SM, Haller JA, Zimmer-Galler I, Zeimer R, Campochioaro PA, Vitale S: Comparison between retinal thickness analyzer and optical coherence tomography for assessment of foveal thickness in eyes with macular disease. Am J Ophthalmol 2002, 134, 240-251.
12. Jonas JB, Dagenring RF, Kressig I, Akkoyun I, Kamppeter BA: Intraocular pressure elevation after intravitreal triamcinolne acetonide injection. Ophthalmology 2005, 112(4), 593-598.
13. Jonas JB, Kressig I, Degenring RF: Intravitreal triamcinolone acetonide as treatment of macular edema in central vein occlusion. Graef Arch Clin Exp Ophthalmol 2002, 240, 782-783.
14. Jaissle GB, Szurman P, Bartz-Schmidt KU: Nebenwirkungen und Komplikationen der intravitrealen Triamcinolnacetonis-Therapie. Ophthalmologe 2004, 101, 121-128.